What they were paid
CHAMPIONS ONCOLOGY Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2026 | $0 | $0 | $98,226 | $0 | $98,226 |
| FY2025 | $0 | $0 | $118,418 | $0 | $118,418 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CHAMPIONS ONCOLOGY, INC. DEF 14A filed August 28, 2026, accession 0001628280-26-059373, and prior-year filings. Open the filing on EDGAR.
Committees
FY2026 · as the proxy prints themAudit · Nominating/Governance
The rest of the CHAMPIONS ONCOLOGY board
FY2026 · as the company reported each| Director | Role | FY2026 total |
|---|---|---|
| Brian Alexander | Independent Director | $15,764 |
| Daniel Mendelson | Independent Director | $95,225 |
| David Sidransky | Independent Director | $81,890 |
| Robert Brainin | Director | $40,622 |
| Ronnie Morris | Chair of the Board | $75,000 |
| Scott R. Tobin | Independent Director | $94,898 |
The full CHAMPIONS ONCOLOGY compensation record
free company briefThis page is one director within CHAMPIONS ONCOLOGY's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat